Brad Fugere Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Biography and Research Information
OverviewAI-generated summary
Brad Fugere's research investigates various aspects of cardiovascular health, immune oncology, and rare dendritic cell neoplasms. His work includes real-world analyses of cardiovascular outcomes for lipid-lowering therapies, comparing treatments like inclisiran with PCSK9 monoclonal antibodies. He has also examined the cardioprotective effects of beta-blocker therapy initiated post-myocardial infarction in patients with preserved ejection fraction, utilizing propensity-matched analyses. Fugere's publications also address outcomes in CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and the characteristics and survival outcomes for rare dendritic cell neoplasms. Additionally, his research explores the predictive value of weight loss for immune oncology responses and the clinical implications of tumor-immune interactions.
Metrics
- h-index: 1
- Publications: 9
- Citations: 1
Selected Publications
-
Examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram (2026)
-
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
-
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)
-
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)
-
Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024)
-
Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms (2023)
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics